UK Markets closed
  • FTSE 100

    7,466.07
    -88.24 (-1.17%)
     
  • FTSE 250

    21,643.30
    -211.27 (-0.97%)
     
  • AIM

    1,082.51
    -4.13 (-0.38%)
     
  • GBP/EUR

    1.2015
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.3391
    +0.0009 (+0.0710%)
     
  • BTC-GBP

    27,916.79
    +971.21 (+3.60%)
     
  • CMC Crypto 200

    850.11
    +7.65 (+0.91%)
     
  • S&P 500

    4,398.04
    +71.53 (+1.65%)
     
  • DOW

    34,520.14
    +359.36 (+1.05%)
     
  • CRUDE OIL

    86.83
    +0.22 (+0.25%)
     
  • GOLD FUTURES

    1,789.20
    -5.80 (-0.32%)
     
  • NIKKEI 225

    26,717.34
    +547.04 (+2.09%)
     
  • HANG SENG

    23,550.08
    -256.92 (-1.08%)
     
  • DAX

    15,318.95
    -205.32 (-1.32%)
     
  • CAC 40

    6,965.88
    -57.92 (-0.82%)
     

Is Ingevity Corporation's (NYSE:NGVT) 21% ROE Better Than Average?

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • NGVT

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Ingevity Corporation (NYSE:NGVT).

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Put another way, it reveals the company's success at turning shareholder investments into profits.

Check out our latest analysis for Ingevity

How To Calculate Return On Equity?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Ingevity is:

21% = US$135m ÷ US$645m (Based on the trailing twelve months to September 2021).

The 'return' is the yearly profit. That means that for every $1 worth of shareholders' equity, the company generated $0.21 in profit.

Does Ingevity Have A Good ROE?

Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. The limitation of this approach is that some companies are quite different from others, even within the same industry classification. As you can see in the graphic below, Ingevity has a higher ROE than the average (14%) in the Chemicals industry.

roe
roe

That's clearly a positive. However, bear in mind that a high ROE doesn’t necessarily indicate efficient profit generation. Especially when a firm uses high levels of debt to finance its debt which may boost its ROE but the high leverage puts the company at risk. To know the 3 risks we have identified for Ingevity visit our risks dashboard for free.

Why You Should Consider Debt When Looking At ROE

Most companies need money -- from somewhere -- to grow their profits. That cash can come from issuing shares, retained earnings, or debt. In the first and second cases, the ROE will reflect this use of cash for investment in the business. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. That will make the ROE look better than if no debt was used.

Ingevity's Debt And Its 21% ROE

Ingevity does use a high amount of debt to increase returns. It has a debt to equity ratio of 1.83. While its ROE is respectable, it is worth keeping in mind that there is usually a limit as to how much debt a company can use. Debt increases risk and reduces options for the company in the future, so you generally want to see some good returns from using it.

Conclusion

Return on equity is one way we can compare its business quality of different companies. In our books, the highest quality companies have high return on equity, despite low debt. If two companies have the same ROE, then I would generally prefer the one with less debt.

But when a business is high quality, the market often bids it up to a price that reflects this. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So you might want to check this FREE visualization of analyst forecasts for the company.

Of course Ingevity may not be the best stock to buy. So you may wish to see this free collection of other companies that have high ROE and low debt.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting